Switch Bioworks is a technology company.
Switch Bioworks has raised $4.0M across 1 funding round.
Switch Bioworks has raised $4.0M in total across 1 funding round.
Switch Bioworks has raised $4.0M in total across 1 funding round.
Switch Bioworks's investors include Acre Venture Partners, Bow Capital.
Switch Bioworks is an early-stage biotechnology startup founded in 2022 as a spinout from Stanford University, focused on engineering the plant microbiome using synthetic biology to produce sustainable, controllable nitrogen fertilizers directly at plant roots.[1][2][3][4] The company reprograms naturally occurring symbiotic microbes into "fertilizer-producing mini-factories," displacing industrial nitrogen fertilizers that cause environmental damage like pollution, runoff, and toxic emissions, with an initial target of corn crops in the US.[1][2][4][5] It serves farmers seeking cost-effective, eco-friendly alternatives, solving agricultural bottlenecks in fertilizer production amid a growing global food demand, while aiming for yield parity and manufacturing costs around $1 per acre at scale.[2][5] With a team of 12-20 scientists specializing in synthetic biology, genome editing, and microbial ecology, Switch has raised $17 million in seed funding, expanded facilities in San Carlos, CA, and plans commercial products by 2028, showing strong growth momentum through leadership hires and field trials starting in 2025.[1][3][5]
Switch Bioworks was founded in March 2022 by Dr. Tim Schnabel, who serves as CEO, emerging from Stanford University research on synthetic biology and plant microbiomes.[1][2][3][5] The idea stemmed from addressing the environmental harm of industrial nitrogen fertilizers, with Schnabel pioneering genetic "switches" that enable engineered microbes to colonize plant roots before activating fertilizer production in response to environmental triggers, overcoming key challenges in biofertilizers.[5] Early traction included assembling a diverse team of experts in metabolic engineering, evolutionary biology, and soil ecology; securing a $17 million seed round in summer 2024; and advancing through product development with greenhouse and field testing underway by 2025.[1][2][5] Pivotal moments include the August 2025 leadership expansion with senior executives like Dr. Boghigian and relocation to a tripled-size facility equipped for fermentation, plant growth, and R&D, marking a shift to customer-driven innovation.[3]
Switch Bioworks stands out in the biofertilizer space through several key innovations:
Switch Bioworks rides the wave of synthetic biology and precision agriculture trends, addressing climate-driven demands for sustainable farming amid fertilizer market volatility and environmental regulations.[1][2][5] Timing is ideal post-2022 founding, aligning with rising biofertilizer adoption, US corn's massive nitrogen needs, and global food security pressures, where even partial replacement could transform yields and reduce planetary damage.[5][6] Market forces like falling synbio costs, grower partnerships, and field trial momentum favor it, while its BPIA membership and SynBioBeta visibility amplify influence.[3][5][6] By enabling switchable biofertilizers for any crop/region, Switch influences the ecosystem toward microbiome tech, potentially disrupting the $200B+ fertilizer industry and accelerating "regenerative ag" alongside peers in biologicals.[2][4][5]
Switch Bioworks is poised for breakthroughs with 2025 field trials scaling to 2028 commercialization, leveraging its $17M funding, expanded leadership, and facilities to validate switches for corn and beyond.[3][5] Trends like AI-driven synbio design, regulatory tailwinds for biologicals, and farmer economics will shape its path, potentially expanding to other nutrients or crops if colonization proves robust across soils.[5] Its influence may evolve from R&D pioneer to market leader, fostering partnerships and setting standards for controllable microbiomes—ultimately feeding the world sustainably, as its Stanford roots envisioned.[1][3] This earthshot positions Switch as a biotech force in resilient agriculture.
Switch Bioworks has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2022 | $4.0M Seed | Acre Venture Partners, Bow Capital |